posted on 2025-03-31, 11:00authored byLaura KusinskiLaura Kusinski, Danielle Jones, Nooria Atta, Elizabeth Turner, Suzanne Smith, Linda M Oude Griep, Kirsten Rennie, Emanuella De Lucia Rolfe, Stephen J Sharp, Vern Farewell, Helen R Murphy, Roy Taylor, Claire MeekClaire Meek
<p dir="ltr">Reduced-energy diets promote weight loss and improve long-term outcomes in type 2 diabetes but are untested in gestational diabetes. We aimed to identify if weight loss in pregnancy improves perinatal outcomes in gestational diabetes. We performed a multicentre parallel, randomized, controlled, double-blind trial of energy restriction in women with singleton pregnancies, gestational diabetes and body mass index ≥25 kg m− 2. Participants were randomized to receive a standard-energy control diet (2,000 kcal d−1) or reduced-energy intervention diet (1,200 kcal d−1) from enrollment (29 weeks) until delivery, provided as weekly diet boxes (40% carbohydrate, 35% fat, 25% protein). The randomization was performed in a 1:1 ratio, stratified by center and blinded to the participants and study team. Primary outcomes were maternal weight change from enrollment to 36 weeks and offspring birth weight. In total, 425 participants were randomized to the control (n = 211) or intervention (n = 214). Outcome data were available for 388 of 425 (90.1%) participants at 36 weeks and 382 of 425 (89.8%) at delivery. There was no evidence of a difference in maternal weight change to 36 weeks between groups (intervention effect −0.20 (95% confidence interval −1.01, 0.61); P > 0.1) and offspring standardized birth weight (intervention effect 0.005 (−0.19, 0.20); P > 0.1). A reduced-energy diet was safe in pregnancy. ISRCTN registration no. 65152174.</p>
To adhere to General Data Protection Regulation (https://gdpr-info.eu/), data will not be uploaded to a repository in advance of publication due to the potential for subject identification. Anonymized individual participant data is available upon request from the corresponding author (cm881@leicester.ac.uk), subject to approval from trial steering groups and data sharing and processing agreements. The timeframe for responding to data requests from the authors is within 1 month.